(Q41813107)

12 October 2017

0 references

Opportunistic infections in patients treated with immunotherapy for cancer (English)

1 reference

12 October 2017

1 reference

opportunistic infection

1 reference

3

Jedd D Wolchok

1 reference

12 October 2017

Chrisann Kyi

1

1 reference

12 October 2017

Matthew D Hellmann

series ordinal

2

1 reference

12 October 2017

Paul B Chapman

series ordinal

4

1 reference

12 October 2017

Michael A Postow

series ordinal

5

1 reference

12 October 2017

18 June 2014

1 reference

Journal for Immunotherapy of Cancer

12 October 2017

1 reference

12 October 2017

2

1 reference

12 October 2017

19

1 reference

https://scigraph.springernature.com/pub.10.1186/2051-1426-2-19

12 October 2017

0 references

cites work

Survival, durable tumor remission, and long-term safety in patients with advanced melanoma receiving nivolumab

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4079190

Safety, efficacy, and biomarkers of nivolumab with vaccine in ipilimumab-refractory or -naive melanoma

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4079190

Safety and Tumor Responses with Lambrolizumab (Anti–PD-1) in Melanoma

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4079190

Safety, activity, and immune correlates of anti-PD-1 antibody in cancer

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4079190

Management of immune-related adverse events and kinetics of response with ipilimumab

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4079190

Ipilimumab plus dacarbazine for previously untreated metastatic melanoma

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4079190

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4079190

Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4079190

6 June 2018

Identifiers

DOI

10.1186/2051-1426-2-19

1 reference

12 October 2017

1 reference

12 October 2017

1 reference